The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications. 

The group's hope is that these new funds will help address the rising rates of PAD and CLTI throughout the United States.

Students sometimes take unprescribed Adderall to stay up late and study. According to new research out of Mayo Clinic, however, that may do more to the heart than those students realize. 

These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.

Recor Medical's Paradise Ultrasound RDN technology is now available in Japan, home to an estimated 43 million adults with hypertension.

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

Newer imaging technologies designed to use less radiation have made a considerable impact. In parts of the world where those systems have not yet been implemented, however, radiation dose levels remain quite high. 

The updated reader is 60% smaller and offers built-in WiFi connectivity. It works with an implantable sensor to monitor a patient's PA pressure. 

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 

AF Symposium 2026 in Boston included new data from some of the biggest names in electrophysiology. Johnson & Johnson MedTech, Abbott, Atraverse Medical, Field Medical, Pulse Biosciences, Argá Medtech SA and CardioFocus were just some of the medtech companies at the heart of late-breaking presentations. 

An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care. 

The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.

As of 2024, some 32% of hospital nurses indicated they remained unhappy on the job. No less troublingly, more than a quarter said they wanted to quit work outright. 

The study by the nonprofit KFF is focused on the jump in overall healthcare prices from 2022 to 2024, with hospitals leading as a result of both delayed care from the pandemic and an increase in prices for services.